Product Code:460577
Published Date: Feb 08,2023
Pages: 129
Region: Global
Category: Pharma & Healthcare
PDF DOWNLOAD
GET FREE SAMPLE
CUSTOMIZE REQUEST
PDF DOWNLOAD
GET FREE SAMPLE
CUSTOMIZE REQUEST
SELECT A FORMAT
ADD TO BASKET
BUY NOW
Provide comprehensive and accurate analysis and reports according to your exact requirements
Point-of-care testing (POCT or bedside testing) is defined as medical diagnostic testing at or near the point of care—that is, at the time and place of patient care. In our report, blood glucose test strips and blood glucose meter, which mainly used at home, are not included. LPI (LP Information)' newest research report, the “Point-Of-Care Or Rapid Diagnostics Industry Forecast” looks at past sales and reviews total world Point-Of-Care Or Rapid Diagnostics sales in 2022, providing a comprehensive analysis by region and market sector of projected Point-Of-Care Or Rapid Diagnostics sales for 2023 through 2029. With Point-Of-Care Or Rapid Diagnostics sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Point-Of-Care Or Rapid Diagnostics industry. This Insight Report provides a comprehensive analysis of the global Point-Of-Care Or Rapid Diagnostics landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Point-Of-Care Or Rapid Diagnostics portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Point-Of-Care Or Rapid Diagnostics market. This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Point-Of-Care Or Rapid Diagnostics and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Point-Of-Care Or Rapid Diagnostics. The global Point-Of-Care Or Rapid Diagnostics market size is projected to grow from US$ 25110 million in 2022 to US$ 48170 million in 2029; it is expected to grow at a CAGR of 48170 from 2023 to 2029. In Spain & Portugal Market, Oint-of-Care or Rapid Diagnostics key players include, Roche, Abbott, Danaher, Siemens Healthcare, Bio-Rad Laboratories, etc. Top 5 manufacturers hold a share over 74%. In terms of product, Intensive Care is the largest segment, with a share over 19%. And in terms of application, the largest application is Hospital, followed by Clinic, Independent Laboratories and Others. This report presents a comprehensive overview, market shares, and growth opportunities of Point-Of-Care Or Rapid Diagnostics market by product type, application, key manufacturers and key regions and countries. Market Segmentation: Segmentation by type Intensive Care Covid-19 Testing Infectious Diseases Testing Cardiac Markers Testing Coagulation Testing Others Segmentation by application Hospital Clinic Independent Laboratories Others This report also splits the market by region: Americas United States Canada Mexico Brazil APAC China Japan Korea Southeast Asia India Australia Europe Germany France UK Italy Russia Middle East & Africa Egypt South Africa Israel Turkey GCC Countries The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration. Roche Abbott Danaher Siemens Healthcare Bio-Rad Laboratories BioMerieux Nova Biomedical Thermo Fisher Scientific Quidel A. Menarini Diagnostics Becton Dickinson Biosurfit Astrego Diagnostics Werfen Abionic Palex Medical/Bülhmann Horiba Medical RAL Vircell Monlab Binding Site Key Questions Addressed in this Report What is the 10-year outlook for the global Point-Of-Care Or Rapid Diagnostics market? What factors are driving Point-Of-Care Or Rapid Diagnostics market growth, globally and by region? Which technologies are poised for the fastest growth by market and region? How do Point-Of-Care Or Rapid Diagnostics market opportunities vary by end market size? How does Point-Of-Care Or Rapid Diagnostics break out type, application? What are the influences of COVID-19 and Russia-Ukraine war?
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Point-Of-Care Or Rapid Diagnostics Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Point-Of-Care Or Rapid Diagnostics by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Point-Of-Care Or Rapid Diagnostics by Country/Region, 2018, 2022 & 2029
2.2 Point-Of-Care Or Rapid Diagnostics Segment by Type
2.2.1 Intensive Care
2.2.2 Covid-19 Testing
2.2.3 Infectious Diseases Testing
2.2.4 Cardiac Markers Testing
2.2.5 Coagulation Testing
2.2.6 Others
2.3 Point-Of-Care Or Rapid Diagnostics Sales by Type
2.3.1 Global Point-Of-Care Or Rapid Diagnostics Sales Market Share by Type (2018-2023)
2.3.2 Global Point-Of-Care Or Rapid Diagnostics Revenue and Market Share by Type (2018-2023)
2.3.3 Global Point-Of-Care Or Rapid Diagnostics Sale Price by Type (2018-2023)
2.4 Point-Of-Care Or Rapid Diagnostics Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Independent Laboratories
2.4.4 Others
2.5 Point-Of-Care Or Rapid Diagnostics Sales by Application
2.5.1 Global Point-Of-Care Or Rapid Diagnostics Sale Market Share by Application (2018-2023)
2.5.2 Global Point-Of-Care Or Rapid Diagnostics Revenue and Market Share by Application (2018-2023)
2.5.3 Global Point-Of-Care Or Rapid Diagnostics Sale Price by Application (2018-2023)
3 Global Point-Of-Care Or Rapid Diagnostics by Company
3.1 Global Point-Of-Care Or Rapid Diagnostics Breakdown Data by Company
3.1.1 Global Point-Of-Care Or Rapid Diagnostics Annual Sales by Company (2018-2023)
3.1.2 Global Point-Of-Care Or Rapid Diagnostics Sales Market Share by Company (2018-2023)
3.2 Global Point-Of-Care Or Rapid Diagnostics Annual Revenue by Company (2018-2023)
3.2.1 Global Point-Of-Care Or Rapid Diagnostics Revenue by Company (2018-2023)
3.2.2 Global Point-Of-Care Or Rapid Diagnostics Revenue Market Share by Company (2018-2023)
3.3 Global Point-Of-Care Or Rapid Diagnostics Sale Price by Company
3.4 Key Manufacturers Point-Of-Care Or Rapid Diagnostics Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Point-Of-Care Or Rapid Diagnostics Product Location Distribution
3.4.2 Players Point-Of-Care Or Rapid Diagnostics Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Point-Of-Care Or Rapid Diagnostics by Geographic Region
4.1 World Historic Point-Of-Care Or Rapid Diagnostics Market Size by Geographic Region (2018-2023)
4.1.1 Global Point-Of-Care Or Rapid Diagnostics Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Point-Of-Care Or Rapid Diagnostics Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Point-Of-Care Or Rapid Diagnostics Market Size by Country/Region (2018-2023)
4.2.1 Global Point-Of-Care Or Rapid Diagnostics Annual Sales by Country/Region (2018-2023)
4.2.2 Global Point-Of-Care Or Rapid Diagnostics Annual Revenue by Country/Region (2018-2023)
4.3 Americas Point-Of-Care Or Rapid Diagnostics Sales Growth
4.4 APAC Point-Of-Care Or Rapid Diagnostics Sales Growth
4.5 Europe Point-Of-Care Or Rapid Diagnostics Sales Growth
4.6 Middle East & Africa Point-Of-Care Or Rapid Diagnostics Sales Growth
5 Americas
5.1 Americas Point-Of-Care Or Rapid Diagnostics Sales by Country
5.1.1 Americas Point-Of-Care Or Rapid Diagnostics Sales by Country (2018-2023)
5.1.2 Americas Point-Of-Care Or Rapid Diagnostics Revenue by Country (2018-2023)
5.2 Americas Point-Of-Care Or Rapid Diagnostics Sales by Type
5.3 Americas Point-Of-Care Or Rapid Diagnostics Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Point-Of-Care Or Rapid Diagnostics Sales by Region
6.1.1 APAC Point-Of-Care Or Rapid Diagnostics Sales by Region (2018-2023)
6.1.2 APAC Point-Of-Care Or Rapid Diagnostics Revenue by Region (2018-2023)
6.2 APAC Point-Of-Care Or Rapid Diagnostics Sales by Type
6.3 APAC Point-Of-Care Or Rapid Diagnostics Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Point-Of-Care Or Rapid Diagnostics by Country
7.1.1 Europe Point-Of-Care Or Rapid Diagnostics Sales by Country (2018-2023)
7.1.2 Europe Point-Of-Care Or Rapid Diagnostics Revenue by Country (2018-2023)
7.2 Europe Point-Of-Care Or Rapid Diagnostics Sales by Type
7.3 Europe Point-Of-Care Or Rapid Diagnostics Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Point-Of-Care Or Rapid Diagnostics by Country
8.1.1 Middle East & Africa Point-Of-Care Or Rapid Diagnostics Sales by Country (2018-2023)
8.1.2 Middle East & Africa Point-Of-Care Or Rapid Diagnostics Revenue by Country (2018-2023)
8.2 Middle East & Africa Point-Of-Care Or Rapid Diagnostics Sales by Type
8.3 Middle East & Africa Point-Of-Care Or Rapid Diagnostics Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Point-Of-Care Or Rapid Diagnostics
10.3 Manufacturing Process Analysis of Point-Of-Care Or Rapid Diagnostics
10.4 Industry Chain Structure of Point-Of-Care Or Rapid Diagnostics
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Point-Of-Care Or Rapid Diagnostics Distributors
11.3 Point-Of-Care Or Rapid Diagnostics Customer
12 World Forecast Review for Point-Of-Care Or Rapid Diagnostics by Geographic Region
12.1 Global Point-Of-Care Or Rapid Diagnostics Market Size Forecast by Region
12.1.1 Global Point-Of-Care Or Rapid Diagnostics Forecast by Region (2024-2029)
12.1.2 Global Point-Of-Care Or Rapid Diagnostics Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Point-Of-Care Or Rapid Diagnostics Forecast by Type
12.7 Global Point-Of-Care Or Rapid Diagnostics Forecast by Application
13 Key Players Analysis
13.1 Roche
13.1.1 Roche Company Information
13.1.2 Roche Point-Of-Care Or Rapid Diagnostics Product Portfolios and Specifications
13.1.3 Roche Point-Of-Care Or Rapid Diagnostics Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Roche Main Business Overview
13.1.5 Roche Latest Developments
13.2 Abbott
13.2.1 Abbott Company Information
13.2.2 Abbott Point-Of-Care Or Rapid Diagnostics Product Portfolios and Specifications
13.2.3 Abbott Point-Of-Care Or Rapid Diagnostics Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Abbott Main Business Overview
13.2.5 Abbott Latest Developments
13.3 Danaher
13.3.1 Danaher Company Information
13.3.2 Danaher Point-Of-Care Or Rapid Diagnostics Product Portfolios and Specifications
13.3.3 Danaher Point-Of-Care Or Rapid Diagnostics Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Danaher Main Business Overview
13.3.5 Danaher Latest Developments
13.4 Siemens Healthcare
13.4.1 Siemens Healthcare Company Information
13.4.2 Siemens Healthcare Point-Of-Care Or Rapid Diagnostics Product Portfolios and Specifications
13.4.3 Siemens Healthcare Point-Of-Care Or Rapid Diagnostics Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Siemens Healthcare Main Business Overview
13.4.5 Siemens Healthcare Latest Developments
13.5 Bio-Rad Laboratories
13.5.1 Bio-Rad Laboratories Company Information
13.5.2 Bio-Rad Laboratories Point-Of-Care Or Rapid Diagnostics Product Portfolios and Specifications
13.5.3 Bio-Rad Laboratories Point-Of-Care Or Rapid Diagnostics Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Bio-Rad Laboratories Main Business Overview
13.5.5 Bio-Rad Laboratories Latest Developments
13.6 BioMerieux
13.6.1 BioMerieux Company Information
13.6.2 BioMerieux Point-Of-Care Or Rapid Diagnostics Product Portfolios and Specifications
13.6.3 BioMerieux Point-Of-Care Or Rapid Diagnostics Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 BioMerieux Main Business Overview
13.6.5 BioMerieux Latest Developments
13.7 Nova Biomedical
13.7.1 Nova Biomedical Company Information
13.7.2 Nova Biomedical Point-Of-Care Or Rapid Diagnostics Product Portfolios and Specifications
13.7.3 Nova Biomedical Point-Of-Care Or Rapid Diagnostics Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Nova Biomedical Main Business Overview
13.7.5 Nova Biomedical Latest Developments
13.8 Thermo Fisher Scientific
13.8.1 Thermo Fisher Scientific Company Information
13.8.2 Thermo Fisher Scientific Point-Of-Care Or Rapid Diagnostics Product Portfolios and Specifications
13.8.3 Thermo Fisher Scientific Point-Of-Care Or Rapid Diagnostics Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Thermo Fisher Scientific Main Business Overview
13.8.5 Thermo Fisher Scientific Latest Developments
13.9 Quidel
13.9.1 Quidel Company Information
13.9.2 Quidel Point-Of-Care Or Rapid Diagnostics Product Portfolios and Specifications
13.9.3 Quidel Point-Of-Care Or Rapid Diagnostics Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Quidel Main Business Overview
13.9.5 Quidel Latest Developments
13.10 A. Menarini Diagnostics
13.10.1 A. Menarini Diagnostics Company Information
13.10.2 A. Menarini Diagnostics Point-Of-Care Or Rapid Diagnostics Product Portfolios and Specifications
13.10.3 A. Menarini Diagnostics Point-Of-Care Or Rapid Diagnostics Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 A. Menarini Diagnostics Main Business Overview
13.10.5 A. Menarini Diagnostics Latest Developments
13.11 Becton Dickinson
13.11.1 Becton Dickinson Company Information
13.11.2 Becton Dickinson Point-Of-Care Or Rapid Diagnostics Product Portfolios and Specifications
13.11.3 Becton Dickinson Point-Of-Care Or Rapid Diagnostics Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Becton Dickinson Main Business Overview
13.11.5 Becton Dickinson Latest Developments
13.12 Biosurfit
13.12.1 Biosurfit Company Information
13.12.2 Biosurfit Point-Of-Care Or Rapid Diagnostics Product Portfolios and Specifications
13.12.3 Biosurfit Point-Of-Care Or Rapid Diagnostics Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Biosurfit Main Business Overview
13.12.5 Biosurfit Latest Developments
13.13 Astrego Diagnostics
13.13.1 Astrego Diagnostics Company Information
13.13.2 Astrego Diagnostics Point-Of-Care Or Rapid Diagnostics Product Portfolios and Specifications
13.13.3 Astrego Diagnostics Point-Of-Care Or Rapid Diagnostics Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 Astrego Diagnostics Main Business Overview
13.13.5 Astrego Diagnostics Latest Developments
13.14 Werfen
13.14.1 Werfen Company Information
13.14.2 Werfen Point-Of-Care Or Rapid Diagnostics Product Portfolios and Specifications
13.14.3 Werfen Point-Of-Care Or Rapid Diagnostics Sales, Revenue, Price and Gross Margin (2018-2023)
13.14.4 Werfen Main Business Overview
13.14.5 Werfen Latest Developments
13.15 Abionic
13.15.1 Abionic Company Information
13.15.2 Abionic Point-Of-Care Or Rapid Diagnostics Product Portfolios and Specifications
13.15.3 Abionic Point-Of-Care Or Rapid Diagnostics Sales, Revenue, Price and Gross Margin (2018-2023)
13.15.4 Abionic Main Business Overview
13.15.5 Abionic Latest Developments
13.16 Palex Medical/Bülhmann
13.16.1 Palex Medical/Bülhmann Company Information
13.16.2 Palex Medical/Bülhmann Point-Of-Care Or Rapid Diagnostics Product Portfolios and Specifications
13.16.3 Palex Medical/Bülhmann Point-Of-Care Or Rapid Diagnostics Sales, Revenue, Price and Gross Margin (2018-2023)
13.16.4 Palex Medical/Bülhmann Main Business Overview
13.16.5 Palex Medical/Bülhmann Latest Developments
13.17 Horiba Medical
13.17.1 Horiba Medical Company Information
13.17.2 Horiba Medical Point-Of-Care Or Rapid Diagnostics Product Portfolios and Specifications
13.17.3 Horiba Medical Point-Of-Care Or Rapid Diagnostics Sales, Revenue, Price and Gross Margin (2018-2023)
13.17.4 Horiba Medical Main Business Overview
13.17.5 Horiba Medical Latest Developments
13.18 RAL
13.18.1 RAL Company Information
13.18.2 RAL Point-Of-Care Or Rapid Diagnostics Product Portfolios and Specifications
13.18.3 RAL Point-Of-Care Or Rapid Diagnostics Sales, Revenue, Price and Gross Margin (2018-2023)
13.18.4 RAL Main Business Overview
13.18.5 RAL Latest Developments
13.19 Vircell
13.19.1 Vircell Company Information
13.19.2 Vircell Point-Of-Care Or Rapid Diagnostics Product Portfolios and Specifications
13.19.3 Vircell Point-Of-Care Or Rapid Diagnostics Sales, Revenue, Price and Gross Margin (2018-2023)
13.19.4 Vircell Main Business Overview
13.19.5 Vircell Latest Developments
13.20 Monlab
13.20.1 Monlab Company Information
13.20.2 Monlab Point-Of-Care Or Rapid Diagnostics Product Portfolios and Specifications
13.20.3 Monlab Point-Of-Care Or Rapid Diagnostics Sales, Revenue, Price and Gross Margin (2018-2023)
13.20.4 Monlab Main Business Overview
13.20.5 Monlab Latest Developments
13.21 Binding Site
13.21.1 Binding Site Company Information
13.21.2 Binding Site Point-Of-Care Or Rapid Diagnostics Product Portfolios and Specifications
13.21.3 Binding Site Point-Of-Care Or Rapid Diagnostics Sales, Revenue, Price and Gross Margin (2018-2023)
13.21.4 Binding Site Main Business Overview
13.21.5 Binding Site Latest Developments
14 Research Findings and Conclusion
List of Tables Table 1. Point-Of-Care Or Rapid Diagnostics Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions) Table 2. Point-Of-Care Or Rapid Diagnostics Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions) Table 3. Major Players of Intensive Care Table 4. Major Players of Covid-19 Testing Table 5. Major Players of Infectious Diseases Testing Table 6. Major Players of Cardiac Markers Testing Table 7. Major Players of Coagulation Testing Table 8. Major Players of Others Table 9. Global Point-Of-Care Or Rapid Diagnostics Sales by Type (2018-2023) & (K Doses) Table 10. Global Point-Of-Care Or Rapid Diagnostics Sales Market Share by Type (2018-2023) Table 11. Global Point-Of-Care Or Rapid Diagnostics Revenue by Type (2018-2023) & ($ million) Table 12. Global Point-Of-Care Or Rapid Diagnostics Revenue Market Share by Type (2018-2023) Table 13. Global Point-Of-Care Or Rapid Diagnostics Sale Price by Type (2018-2023) & (US$/Dose) Table 14. Global Point-Of-Care Or Rapid Diagnostics Sales by Application (2018-2023) & (K Doses) Table 15. Global Point-Of-Care Or Rapid Diagnostics Sales Market Share by Application (2018-2023) Table 16. Global Point-Of-Care Or Rapid Diagnostics Revenue by Application (2018-2023) Table 17. Global Point-Of-Care Or Rapid Diagnostics Revenue Market Share by Application (2018-2023) Table 18. Global Point-Of-Care Or Rapid Diagnostics Sale Price by Application (2018-2023) & (US$/Dose) Table 19. Global Point-Of-Care Or Rapid Diagnostics Sales by Company (2018-2023) & (K Doses) Table 20. Global Point-Of-Care Or Rapid Diagnostics Sales Market Share by Company (2018-2023) Table 21. Global Point-Of-Care Or Rapid Diagnostics Revenue by Company (2018-2023) ($ Millions) Table 22. Global Point-Of-Care Or Rapid Diagnostics Revenue Market Share by Company (2018-2023) Table 23. Global Point-Of-Care Or Rapid Diagnostics Sale Price by Company (2018-2023) & (US$/Dose) Table 24. Key Manufacturers Point-Of-Care Or Rapid Diagnostics Producing Area Distribution and Sales Area Table 25. Players Point-Of-Care Or Rapid Diagnostics Products Offered Table 26. Point-Of-Care Or Rapid Diagnostics Concentration Ratio (CR3, CR5 and CR10) & (2018-2023) Table 27. New Products and Potential Entrants Table 28. Mergers & Acquisitions, Expansion Table 29. Global Point-Of-Care Or Rapid Diagnostics Sales by Geographic Region (2018-2023) & (K Doses) Table 30. Global Point-Of-Care Or Rapid Diagnostics Sales Market Share Geographic Region (2018-2023) Table 31. Global Point-Of-Care Or Rapid Diagnostics Revenue by Geographic Region (2018-2023) & ($ millions) Table 32. Global Point-Of-Care Or Rapid Diagnostics Revenue Market Share by Geographic Region (2018-2023) Table 33. Global Point-Of-Care Or Rapid Diagnostics Sales by Country/Region (2018-2023) & (K Doses) Table 34. Global Point-Of-Care Or Rapid Diagnostics Sales Market Share by Country/Region (2018-2023) Table 35. Global Point-Of-Care Or Rapid Diagnostics Revenue by Country/Region (2018-2023) & ($ millions) Table 36. Global Point-Of-Care Or Rapid Diagnostics Revenue Market Share by Country/Region (2018-2023) Table 37. Americas Point-Of-Care Or Rapid Diagnostics Sales by Country (2018-2023) & (K Doses) Table 38. Americas Point-Of-Care Or Rapid Diagnostics Sales Market Share by Country (2018-2023) Table 39. Americas Point-Of-Care Or Rapid Diagnostics Revenue by Country (2018-2023) & ($ Millions) Table 40. Americas Point-Of-Care Or Rapid Diagnostics Revenue Market Share by Country (2018-2023) Table 41. Americas Point-Of-Care Or Rapid Diagnostics Sales by Type (2018-2023) & (K Doses) Table 42. Americas Point-Of-Care Or Rapid Diagnostics Sales by Application (2018-2023) & (K Doses) Table 43. APAC Point-Of-Care Or Rapid Diagnostics Sales by Region (2018-2023) & (K Doses) Table 44. APAC Point-Of-Care Or Rapid Diagnostics Sales Market Share by Region (2018-2023) Table 45. APAC Point-Of-Care Or Rapid Diagnostics Revenue by Region (2018-2023) & ($ Millions) Table 46. APAC Point-Of-Care Or Rapid Diagnostics Revenue Market Share by Region (2018-2023) Table 47. APAC Point-Of-Care Or Rapid Diagnostics Sales by Type (2018-2023) & (K Doses) Table 48. APAC Point-Of-Care Or Rapid Diagnostics Sales by Application (2018-2023) & (K Doses) Table 49. Europe Point-Of-Care Or Rapid Diagnostics Sales by Country (2018-2023) & (K Doses) Table 50. Europe Point-Of-Care Or Rapid Diagnostics Sales Market Share by Country (2018-2023) Table 51. Europe Point-Of-Care Or Rapid Diagnostics Revenue by Country (2018-2023) & ($ Millions) Table 52. Europe Point-Of-Care Or Rapid Diagnostics Revenue Market Share by Country (2018-2023) Table 53. Europe Point-Of-Care Or Rapid Diagnostics Sales by Type (2018-2023) & (K Doses) Table 54. Europe Point-Of-Care Or Rapid Diagnostics Sales by Application (2018-2023) & (K Doses) Table 55. Middle East & Africa Point-Of-Care Or Rapid Diagnostics Sales by Country (2018-2023) & (K Doses) Table 56. Middle East & Africa Point-Of-Care Or Rapid Diagnostics Sales Market Share by Country (2018-2023) Table 57. Middle East & Africa Point-Of-Care Or Rapid Diagnostics Revenue by Country (2018-2023) & ($ Millions) Table 58. Middle East & Africa Point-Of-Care Or Rapid Diagnostics Revenue Market Share by Country (2018-2023) Table 59. Middle East & Africa Point-Of-Care Or Rapid Diagnostics Sales by Type (2018-2023) & (K Doses) Table 60. Middle East & Africa Point-Of-Care Or Rapid Diagnostics Sales by Application (2018-2023) & (K Doses) Table 61. Key Market Drivers & Growth Opportunities of Point-Of-Care Or Rapid Diagnostics Table 62. Key Market Challenges & Risks of Point-Of-Care Or Rapid Diagnostics Table 63. Key Industry Trends of Point-Of-Care Or Rapid Diagnostics Table 64. Point-Of-Care Or Rapid Diagnostics Raw Material Table 65. Key Suppliers of Raw Materials Table 66. Point-Of-Care Or Rapid Diagnostics Distributors List Table 67. Point-Of-Care Or Rapid Diagnostics Customer List Table 68. Global Point-Of-Care Or Rapid Diagnostics Sales Forecast by Region (2024-2029) & (K Doses) Table 69. Global Point-Of-Care Or Rapid Diagnostics Revenue Forecast by Region (2024-2029) & ($ millions) Table 70. Americas Point-Of-Care Or Rapid Diagnostics Sales Forecast by Country (2024-2029) & (K Doses) Table 71. Americas Point-Of-Care Or Rapid Diagnostics Revenue Forecast by Country (2024-2029) & ($ millions) Table 72. APAC Point-Of-Care Or Rapid Diagnostics Sales Forecast by Region (2024-2029) & (K Doses) Table 73. APAC Point-Of-Care Or Rapid Diagnostics Revenue Forecast by Region (2024-2029) & ($ millions) Table 74. Europe Point-Of-Care Or Rapid Diagnostics Sales Forecast by Country (2024-2029) & (K Doses) Table 75. Europe Point-Of-Care Or Rapid Diagnostics Revenue Forecast by Country (2024-2029) & ($ millions) Table 76. Middle East & Africa Point-Of-Care Or Rapid Diagnostics Sales Forecast by Country (2024-2029) & (K Doses) Table 77. Middle East & Africa Point-Of-Care Or Rapid Diagnostics Revenue Forecast by Country (2024-2029) & ($ millions) Table 78. Global Point-Of-Care Or Rapid Diagnostics Sales Forecast by Type (2024-2029) & (K Doses) Table 79. Global Point-Of-Care Or Rapid Diagnostics Revenue Forecast by Type (2024-2029) & ($ Millions) Table 80. Global Point-Of-Care Or Rapid Diagnostics Sales Forecast by Application (2024-2029) & (K Doses) Table 81. Global Point-Of-Care Or Rapid Diagnostics Revenue Forecast by Application (2024-2029) & ($ Millions) Table 82. Roche Basic Information, Point-Of-Care Or Rapid Diagnostics Manufacturing Base, Sales Area and Its Competitors Table 83. Roche Point-Of-Care Or Rapid Diagnostics Product Portfolios and Specifications Table 84. Roche Point-Of-Care Or Rapid Diagnostics Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2018-2023) Table 85. Roche Main Business Table 86. Roche Latest Developments Table 87. Abbott Basic Information, Point-Of-Care Or Rapid Diagnostics Manufacturing Base, Sales Area and Its Competitors Table 88. Abbott Point-Of-Care Or Rapid Diagnostics Product Portfolios and Specifications Table 89. Abbott Point-Of-Care Or Rapid Diagnostics Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2018-2023) Table 90. Abbott Main Business Table 91. Abbott Latest Developments Table 92. Danaher Basic Information, Point-Of-Care Or Rapid Diagnostics Manufacturing Base, Sales Area and Its Competitors Table 93. Danaher Point-Of-Care Or Rapid Diagnostics Product Portfolios and Specifications Table 94. Danaher Point-Of-Care Or Rapid Diagnostics Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2018-2023) Table 95. Danaher Main Business Table 96. Danaher Latest Developments Table 97. Siemens Healthcare Basic Information, Point-Of-Care Or Rapid Diagnostics Manufacturing Base, Sales Area and Its Competitors Table 98. Siemens Healthcare Point-Of-Care Or Rapid Diagnostics Product Portfolios and Specifications Table 99. Siemens Healthcare Point-Of-Care Or Rapid Diagnostics Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2018-2023) Table 100. Siemens Healthcare Main Business Table 101. Siemens Healthcare Latest Developments Table 102. Bio-Rad Laboratories Basic Information, Point-Of-Care Or Rapid Diagnostics Manufacturing Base, Sales Area and Its Competitors Table 103. Bio-Rad Laboratories Point-Of-Care Or Rapid Diagnostics Product Portfolios and Specifications Table 104. Bio-Rad Laboratories Point-Of-Care Or Rapid Diagnostics Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2018-2023) Table 105. Bio-Rad Laboratories Main Business Table 106. Bio-Rad Laboratories Latest Developments Table 107. BioMerieux Basic Information, Point-Of-Care Or Rapid Diagnostics Manufacturing Base, Sales Area and Its Competitors Table 108. BioMerieux Point-Of-Care Or Rapid Diagnostics Product Portfolios and Specifications Table 109. BioMerieux Point-Of-Care Or Rapid Diagnostics Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2018-2023) Table 110. BioMerieux Main Business Table 111. BioMerieux Latest Developments Table 112. Nova Biomedical Basic Information, Point-Of-Care Or Rapid Diagnostics Manufacturing Base, Sales Area and Its Competitors Table 113. Nova Biomedical Point-Of-Care Or Rapid Diagnostics Product Portfolios and Specifications Table 114. Nova Biomedical Point-Of-Care Or Rapid Diagnostics Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2018-2023) Table 115. Nova Biomedical Main Business Table 116. Nova Biomedical Latest Developments Table 117. Thermo Fisher Scientific Basic Information, Point-Of-Care Or Rapid Diagnostics Manufacturing Base, Sales Area and Its Competitors Table 118. Thermo Fisher Scientific Point-Of-Care Or Rapid Diagnostics Product Portfolios and Specifications Table 119. Thermo Fisher Scientific Point-Of-Care Or Rapid Diagnostics Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2018-2023) Table 120. Thermo Fisher Scientific Main Business Table 121. Thermo Fisher Scientific Latest Developments Table 122. Quidel Basic Information, Point-Of-Care Or Rapid Diagnostics Manufacturing Base, Sales Area and Its Competitors Table 123. Quidel Point-Of-Care Or Rapid Diagnostics Product Portfolios and Specifications Table 124. Quidel Point-Of-Care Or Rapid Diagnostics Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2018-2023) Table 125. Quidel Main Business Table 126. Quidel Latest Developments Table 127. A. Menarini Diagnostics Basic Information, Point-Of-Care Or Rapid Diagnostics Manufacturing Base, Sales Area and Its Competitors Table 128. A. Menarini Diagnostics Point-Of-Care Or Rapid Diagnostics Product Portfolios and Specifications Table 129. A. Menarini Diagnostics Point-Of-Care Or Rapid Diagnostics Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2018-2023) Table 130. A. Menarini Diagnostics Main Business Table 131. A. Menarini Diagnostics Latest Developments Table 132. Becton Dickinson Basic Information, Point-Of-Care Or Rapid Diagnostics Manufacturing Base, Sales Area and Its Competitors Table 133. Becton Dickinson Point-Of-Care Or Rapid Diagnostics Product Portfolios and Specifications Table 134. Becton Dickinson Point-Of-Care Or Rapid Diagnostics Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2018-2023) Table 135. Becton Dickinson Main Business Table 136. Becton Dickinson Latest Developments Table 137. Biosurfit Basic Information, Point-Of-Care Or Rapid Diagnostics Manufacturing Base, Sales Area and Its Competitors Table 138. Biosurfit Point-Of-Care Or Rapid Diagnostics Product Portfolios and Specifications Table 139. Biosurfit Point-Of-Care Or Rapid Diagnostics Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2018-2023) Table 140. Biosurfit Main Business Table 141. Biosurfit Latest Developments Table 142. Astrego Diagnostics Basic Information, Point-Of-Care Or Rapid Diagnostics Manufacturing Base, Sales Area and Its Competitors Table 143. Astrego Diagnostics Point-Of-Care Or Rapid Diagnostics Product Portfolios and Specifications Table 144. Astrego Diagnostics Point-Of-Care Or Rapid Diagnostics Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2018-2023) Table 145. Astrego Diagnostics Main Business Table 146. Astrego Diagnostics Latest Developments Table 147. Werfen Basic Information, Point-Of-Care Or Rapid Diagnostics Manufacturing Base, Sales Area and Its Competitors Table 148. Werfen Point-Of-Care Or Rapid Diagnostics Product Portfolios and Specifications Table 149. Werfen Point-Of-Care Or Rapid Diagnostics Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2018-2023) Table 150. Werfen Main Business Table 151. Werfen Latest Developments Table 152. Abionic Basic Information, Point-Of-Care Or Rapid Diagnostics Manufacturing Base, Sales Area and Its Competitors Table 153. Abionic Point-Of-Care Or Rapid Diagnostics Product Portfolios and Specifications Table 154. Abionic Point-Of-Care Or Rapid Diagnostics Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2018-2023) Table 155. Abionic Main Business Table 156. Abionic Latest Developments Table 157. Palex Medical/Bülhmann Basic Information, Point-Of-Care Or Rapid Diagnostics Manufacturing Base, Sales Area and Its Competitors Table 158. Palex Medical/Bülhmann Point-Of-Care Or Rapid Diagnostics Product Portfolios and Specifications Table 159. Palex Medical/Bülhmann Point-Of-Care Or Rapid Diagnostics Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2018-2023) Table 160. Palex Medical/Bülhmann Main Business Table 161. Palex Medical/Bülhmann Latest Developments Table 162. Horiba Medical Basic Information, Point-Of-Care Or Rapid Diagnostics Manufacturing Base, Sales Area and Its Competitors Table 163. Horiba Medical Point-Of-Care Or Rapid Diagnostics Product Portfolios and Specifications Table 164. Horiba Medical Point-Of-Care Or Rapid Diagnostics Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2018-2023) Table 165. Horiba Medical Main Business Table 166. Horiba Medical Latest Developments Table 167. RAL Basic Information, Point-Of-Care Or Rapid Diagnostics Manufacturing Base, Sales Area and Its Competitors Table 168. RAL Point-Of-Care Or Rapid Diagnostics Product Portfolios and Specifications Table 169. RAL Point-Of-Care Or Rapid Diagnostics Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2018-2023) Table 170. RAL Main Business Table 171. RAL Latest Developments Table 172. Vircell Basic Information, Point-Of-Care Or Rapid Diagnostics Manufacturing Base, Sales Area and Its Competitors Table 173. Vircell Point-Of-Care Or Rapid Diagnostics Product Portfolios and Specifications Table 174. Vircell Point-Of-Care Or Rapid Diagnostics Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2018-2023) Table 175. Vircell Main Business Table 176. Vircell Latest Developments Table 177. Monlab Basic Information, Point-Of-Care Or Rapid Diagnostics Manufacturing Base, Sales Area and Its Competitors Table 178. Monlab Point-Of-Care Or Rapid Diagnostics Product Portfolios and Specifications Table 179. Monlab Point-Of-Care Or Rapid Diagnostics Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2018-2023) Table 180. Monlab Main Business Table 181. Monlab Latest Developments Table 182. Binding Site Basic Information, Point-Of-Care Or Rapid Diagnostics Manufacturing Base, Sales Area and Its Competitors Table 183. Binding Site Point-Of-Care Or Rapid Diagnostics Product Portfolios and Specifications Table 184. Binding Site Point-Of-Care Or Rapid Diagnostics Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2018-2023) Table 185. Binding Site Main Business Table 186. Binding Site Latest Developments List of Figures Figure 1. Picture of Point-Of-Care Or Rapid Diagnostics Figure 2. Point-Of-Care Or Rapid Diagnostics Report Years Considered Figure 3. Research Objectives Figure 4. Research Methodology Figure 5. Research Process and Data Source Figure 6. Global Point-Of-Care Or Rapid Diagnostics Sales Growth Rate 2018-2029 (K Doses) Figure 7. Global Point-Of-Care Or Rapid Diagnostics Revenue Growth Rate 2018-2029 ($ Millions) Figure 8. Point-Of-Care Or Rapid Diagnostics Sales by Region (2018, 2022 & 2029) & ($ Millions) Figure 9. Product Picture of Intensive Care Figure 10. Product Picture of Covid-19 Testing Figure 11. Product Picture of Infectious Diseases Testing Figure 12. Product Picture of Cardiac Markers Testing Figure 13. Product Picture of Coagulation Testing Figure 14. Product Picture of Others Figure 15. Global Point-Of-Care Or Rapid Diagnostics Sales Market Share by Type in 2022 Figure 16. Global Point-Of-Care Or Rapid Diagnostics Revenue Market Share by Type (2018-2023) Figure 17. Point-Of-Care Or Rapid Diagnostics Consumed in Hospital Figure 18. Global Point-Of-Care Or Rapid Diagnostics Market: Hospital (2018-2023) & (K Doses) Figure 19. Point-Of-Care Or Rapid Diagnostics Consumed in Clinic Figure 20. Global Point-Of-Care Or Rapid Diagnostics Market: Clinic (2018-2023) & (K Doses) Figure 21. Point-Of-Care Or Rapid Diagnostics Consumed in Independent Laboratories Figure 22. Global Point-Of-Care Or Rapid Diagnostics Market: Independent Laboratories (2018-2023) & (K Doses) Figure 23. Point-Of-Care Or Rapid Diagnostics Consumed in Others Figure 24. Global Point-Of-Care Or Rapid Diagnostics Market: Others (2018-2023) & (K Doses) Figure 25. Global Point-Of-Care Or Rapid Diagnostics Sales Market Share by Application (2022) Figure 26. Global Point-Of-Care Or Rapid Diagnostics Revenue Market Share by Application in 2022 Figure 27. Point-Of-Care Or Rapid Diagnostics Sales Market by Company in 2022 (K Doses) Figure 28. Global Point-Of-Care Or Rapid Diagnostics Sales Market Share by Company in 2022 Figure 29. Point-Of-Care Or Rapid Diagnostics Revenue Market by Company in 2022 ($ Million) Figure 30. Global Point-Of-Care Or Rapid Diagnostics Revenue Market Share by Company in 2022 Figure 31. Global Point-Of-Care Or Rapid Diagnostics Sales Market Share by Geographic Region (2018-2023) Figure 32. Global Point-Of-Care Or Rapid Diagnostics Revenue Market Share by Geographic Region in 2022 Figure 33. Americas Point-Of-Care Or Rapid Diagnostics Sales 2018-2023 (K Doses) Figure 34. Americas Point-Of-Care Or Rapid Diagnostics Revenue 2018-2023 ($ Millions) Figure 35. APAC Point-Of-Care Or Rapid Diagnostics Sales 2018-2023 (K Doses) Figure 36. APAC Point-Of-Care Or Rapid Diagnostics Revenue 2018-2023 ($ Millions) Figure 37. Europe Point-Of-Care Or Rapid Diagnostics Sales 2018-2023 (K Doses) Figure 38. Europe Point-Of-Care Or Rapid Diagnostics Revenue 2018-2023 ($ Millions) Figure 39. Middle East & Africa Point-Of-Care Or Rapid Diagnostics Sales 2018-2023 (K Doses) Figure 40. Middle East & Africa Point-Of-Care Or Rapid Diagnostics Revenue 2018-2023 ($ Millions) Figure 41. Americas Point-Of-Care Or Rapid Diagnostics Sales Market Share by Country in 2022 Figure 42. Americas Point-Of-Care Or Rapid Diagnostics Revenue Market Share by Country in 2022 Figure 43. Americas Point-Of-Care Or Rapid Diagnostics Sales Market Share by Type (2018-2023) Figure 44. Americas Point-Of-Care Or Rapid Diagnostics Sales Market Share by Application (2018-2023) Figure 45. United States Point-Of-Care Or Rapid Diagnostics Revenue Growth 2018-2023 ($ Millions) Figure 46. Canada Point-Of-Care Or Rapid Diagnostics Revenue Growth 2018-2023 ($ Millions) Figure 47. Mexico Point-Of-Care Or Rapid Diagnostics Revenue Growth 2018-2023 ($ Millions) Figure 48. Brazil Point-Of-Care Or Rapid Diagnostics Revenue Growth 2018-2023 ($ Millions) Figure 49. APAC Point-Of-Care Or Rapid Diagnostics Sales Market Share by Region in 2022 Figure 50. APAC Point-Of-Care Or Rapid Diagnostics Revenue Market Share by Regions in 2022 Figure 51. APAC Point-Of-Care Or Rapid Diagnostics Sales Market Share by Type (2018-2023) Figure 52. APAC Point-Of-Care Or Rapid Diagnostics Sales Market Share by Application (2018-2023) Figure 53. China Point-Of-Care Or Rapid Diagnostics Revenue Growth 2018-2023 ($ Millions) Figure 54. Japan Point-Of-Care Or Rapid Diagnostics Revenue Growth 2018-2023 ($ Millions) Figure 55. South Korea Point-Of-Care Or Rapid Diagnostics Revenue Growth 2018-2023 ($ Millions) Figure 56. Southeast Asia Point-Of-Care Or Rapid Diagnostics Revenue Growth 2018-2023 ($ Millions) Figure 57. India Point-Of-Care Or Rapid Diagnostics Revenue Growth 2018-2023 ($ Millions) Figure 58. Australia Point-Of-Care Or Rapid Diagnostics Revenue Growth 2018-2023 ($ Millions) Figure 59. China Taiwan Point-Of-Care Or Rapid Diagnostics Revenue Growth 2018-2023 ($ Millions) Figure 60. Europe Point-Of-Care Or Rapid Diagnostics Sales Market Share by Country in 2022 Figure 61. Europe Point-Of-Care Or Rapid Diagnostics Revenue Market Share by Country in 2022 Figure 62. Europe Point-Of-Care Or Rapid Diagnostics Sales Market Share by Type (2018-2023) Figure 63. Europe Point-Of-Care Or Rapid Diagnostics Sales Market Share by Application (2018-2023) Figure 64. Germany Point-Of-Care Or Rapid Diagnostics Revenue Growth 2018-2023 ($ Millions) Figure 65. France Point-Of-Care Or Rapid Diagnostics Revenue Growth 2018-2023 ($ Millions) Figure 66. UK Point-Of-Care Or Rapid Diagnostics Revenue Growth 2018-2023 ($ Millions) Figure 67. Italy Point-Of-Care Or Rapid Diagnostics Revenue Growth 2018-2023 ($ Millions) Figure 68. Russia Point-Of-Care Or Rapid Diagnostics Revenue Growth 2018-2023 ($ Millions) Figure 69. Middle East & Africa Point-Of-Care Or Rapid Diagnostics Sales Market Share by Country in 2022 Figure 70. Middle East & Africa Point-Of-Care Or Rapid Diagnostics Revenue Market Share by Country in 2022 Figure 71. Middle East & Africa Point-Of-Care Or Rapid Diagnostics Sales Market Share by Type (2018-2023) Figure 72. Middle East & Africa Point-Of-Care Or Rapid Diagnostics Sales Market Share by Application (2018-2023) Figure 73. Egypt Point-Of-Care Or Rapid Diagnostics Revenue Growth 2018-2023 ($ Millions) Figure 74. South Africa Point-Of-Care Or Rapid Diagnostics Revenue Growth 2018-2023 ($ Millions) Figure 75. Israel Point-Of-Care Or Rapid Diagnostics Revenue Growth 2018-2023 ($ Millions) Figure 76. Turkey Point-Of-Care Or Rapid Diagnostics Revenue Growth 2018-2023 ($ Millions) Figure 77. GCC Country Point-Of-Care Or Rapid Diagnostics Revenue Growth 2018-2023 ($ Millions) Figure 78. Manufacturing Cost Structure Analysis of Point-Of-Care Or Rapid Diagnostics in 2022 Figure 79. Manufacturing Process Analysis of Point-Of-Care Or Rapid Diagnostics Figure 80. Industry Chain Structure of Point-Of-Care Or Rapid Diagnostics Figure 81. Channels of Distribution Figure 82. Global Point-Of-Care Or Rapid Diagnostics Sales Market Forecast by Region (2024-2029) Figure 83. Global Point-Of-Care Or Rapid Diagnostics Revenue Market Share Forecast by Region (2024-2029) Figure 84. Global Point-Of-Care Or Rapid Diagnostics Sales Market Share Forecast by Type (2024-2029) Figure 85. Global Point-Of-Care Or Rapid Diagnostics Revenue Market Share Forecast by Type (2024-2029) Figure 86. Global Point-Of-Care Or Rapid Diagnostics Sales Market Share Forecast by Application (2024-2029) Figure 87. Global Point-Of-Care Or Rapid Diagnostics Revenue Market Share Forecast by Application (2024-2029)
Roche Abbott Danaher Siemens Healthcare Bio-Rad Laboratories BioMerieux Nova Biomedical Thermo Fisher Scientific Quidel A. Menarini Diagnostics Becton Dickinson Biosurfit Astrego Diagnostics Werfen Abionic Palex Medical/Bülhmann Horiba Medical RAL Vircell Monlab Binding Site
LP Information presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.
Primary Source
Players/Suppliers
Industry Experts
Distributors/Traders
Opinion Leaders
Front-line Staff
Marketing Executives
Secondary Source
Journals and Periodicals
Government Bodies
Annual Reports
Presentations
Paid Databases
LPI Internal Repository
Data Synthesis
Information Gathering
Collation of Data
Estimation of Key Figures
Analysis of Derived Insights
Data Validation
Triangulation with Data Models
Reference Against Proprietary
Databases
Corroboration with Industry Experts
Qualitative Analysis
Market drivers
Market challenges
Market trends
Five forces analysis
Qualitative Analysis
Market size and forecast
Market segmentation
Geographical insights
Competitive landscape
RELATED REPORTS
Aug
2023
According to our LPI (LP Information) latest study, the global Point-of-Care or Rapid Diagnostics market size was valued at US$ 25110 million in 2022. With growing demand in downstream market and recovery from influence of COVID-19 and the Russia-Ukraine War, the Point-of-Care or Rapid Diagnostics is forecast to a readjusted size of US$ 29620 million by 2029 with a CAGR of 2.4% during review period.
$3660.00